Collaboration focuses on continuing to improve time to therapy and medication adherence for patients, while effectively optimizing clinical data
Surescripts, a health information network, has been working to streamline the specialty prescribing and fulfillment process to help specialty pharmacies and physician practices realize decreased phone calls, increased dispense rates and improvements in time to therapy. As part of its latest development, Surescripts is expanding its clinical intelligence services by collaborating with Diameter Health, a company that specializes in clinical data optimization, to offer timely, easily accessible and accurate patient data for specialty pharmacies.
The Surescripts Specialty Medications Gateway is able to automate the way clinical information is gathered and delivered to specialty pharmacies regardless of size, expediting otherwise complex and tedious processes. The Surescripts partnership with Diameter Health is expected to accelerate the ability to incorporate powerful clinical intelligence into the process by providing standardized data that readily communicates comprehensive patient histories, the parties note.
“By generating a high quality, interoperable data asset from multi-source electronic health records and making it available within Surescripts Specialty Medications Gateway, we can reduce time to therapy and free up specialty pharmacists and prescribers to spend more time on patient care,” note Dr. Paulo Pinho, vice president and medical director of innovation at Diameter Health. “This important partnership will help overcome existing challenges by delivering missing or incomplete patient data, and providing it in a way that is actionable for specialty pharmacists, so they can get patients started on therapy faster.”
Is Compounding the Answer to the Semaglutide Shortage? Experts Weigh In
October 30th 2024In this Q&A, Scott Brunner, CEO, and Tenille Davis, Chief Advocacy Officer, of the Alliance for Pharmacy Compounding discuss the challenges faced by patients and healthcare providers due to drug shortages, particularly for semaglutide and other medications.